---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-21-024928"
form_type: "8-K"
ticker: "CSBR"
cik: "0000771856"
company_name: "CHAMPIONS ONCOLOGY, INC."
filed_at: "2021-12-13T23:59:59+00:00"
generated_at: "2026-06-28T01:53:36.816315+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Champions Oncology reports record Q2 revenue $11.8M, up 17% YoY; operating income $263K

## Summary
- Record quarterly revenue of $11.8M, up 17% from $10.1M year ago.
- GAAP operating income of $263K vs. $7K a year ago; non-GAAP operating income $743K vs. $399K.
- Gross margin improved to 52.4% from 44.2% due to reduced outsourcing.
- Cash position $4.8M, no debt; net cash from ops $1.2M in quarter.
- R&D investment increased 39.3% to $2.3M for therapeutic target discovery.

## SEC filing metadata
- accession: 0001628280-21-024928
- form_type: 8-K
- ticker: CSBR
- cik: 0000771856
- company_name: CHAMPIONS ONCOLOGY, INC.
- filed_at: 2021-12-13T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/771856/000162828021024928/0001628280-21-024928-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/771856/000162828021024928/csbr-20211213.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-21-024928
- JSON: https://secwatch.observer/filing/0001628280-21-024928.json
- Plain text: https://secwatch.observer/filing/0001628280-21-024928.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.